Max Robotics — Global Service Robot Directory + US Certification

About

Carlo Brocca is a rising authority in urologic oncology and minimally invasive stone surgery, whose work is reshaping how clinicians approach prostate cancer and complex kidney stones. His most impactful contributions center on focal therapy for prostate cancer, where he has provided the field with two landmark systematic reviews. The first, with 40 citations, rigorously defines oncological success and cancer control in focal therapy, offering a critical framework for standardizing outcomes in this emerging treatment paradigm. His companion review, cited 38 times, systematically evaluates functional outcomes and patient-reported outcome measures (PROMs), establishing the safety profile and quality-of-life benefits that make focal therapy an attractive alternative to radical treatments. Beyond oncology, Brocca has also advanced the understanding of endoscopic combined intrarenal surgery (ECIRS) through a comprehensive scoping review that traces its evolution from historical techniques to modern applications, highlighting its role in optimizing stone-free rates for complex nephrolithiasis. With these high-impact syntheses, Brocca is helping to define evidence-based practice in two rapidly evolving areas of urology, making him a key voice for clinicians and researchers seeking to balance cancer control, functional preservation, and patient-centered care.